Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ryan Willard

2PUBLICATIONS

37CO-AUTHORS

Clinical pharmacology and therapeuticsMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Dec 13, 2024

Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader.

Lawrence B Snyder, Taavi K Neklesa, Ryan R Willard

|May 31, 2024

Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models.

Sheryl M Gough, John J Flanagan, Jessica Teh

Pageof 1

Frequent Collaborators

2 joint publications

Deborah A Gordon

2 joint publications

Jennifer Pizzano

2 joint publications

John Houston

2 joint publications

Richard Gedrich

2 joint publications

Ian C Taylor

1 joint publications

Lawrence B Snyder

1 joint publications

Taavi K Neklesa

1 joint publications

Nicholas Vitale

1 joint publications

Kaitlynn Robling

1 joint publications

David R Langley

Frequent Collaborators

2 joint publications

Deborah A Gordon

2 joint publications

Jennifer Pizzano

2 joint publications

John Houston

2 joint publications

Richard Gedrich

Top Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on : Nov 09, 2020

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on : Aug 13, 2019

See more related videos

Top Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on : Nov 09, 2020

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on : Aug 13, 2019

See more related videos